The carbon dioxide incubators market is estimated to reach USD 752.9 million in 2024. It is estimated that revenue will increase at a CAGR of 5.1% between 2024 and 2034. The market is anticipated to reach USD 1,238.1 million by 2034.
Carbon dioxide incubators are recording growing demand across the world, driven by a greater incidence of infertility. This has consequently resulted in increase in IVF procedures and thus a need for CO2 incubators that are dependable and generate an optimum environment for embryo growth. Advancements in biotechnology and life sciences drive the demand controlled environments for cell culture.
In this scenario, high-quality CO2 incubators is needed as researchers work on cell-based therapies. Moreover, innovations in the area of CO2 incubators make them more attractive to laboratories and clinics by bringing improved features in contamination control and energy efficiency.
Carbon Dioxide Incubators Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 716.4 million |
| Estimated Size, 2024 | USD 752.9 million |
| Projected Size, 2034 | USD 1,238.1 million |
| Value-based CAGR (2024 to 2034) | 5.1% |
As per the data from HSBC, private funding with the biotech industry has increased in the first quarter of 2024. Around 26 companies have secured more than USD 100 million. The biotech industry in USA and Europe has raised USD 6.8 billion in the first three month of 2024 through venture capital funding. Large investment in the biotech sector is a strong indicator of the interest in developing innovative therapies.
With increasing research in understanding disease mechanisms and testing potential treatments, research institutions and pharmaceutical companies need a reliable platform of CO2 incubators to support these expanded activities. Mainly, such incubators play an essential role in ensuring the right conditions for the growth of different cell types, including mammalian and stem cells, which have great importance in drug discovery and personalized medicine.
Moreover, the growing importance of medical treatment paradigms in the area of regenerative medicine and cell-based therapies adds up to a bigger customer demand for CO2 incubators. New treatment methods will require controlled environmental settings of high precision so that cell viability and function can be ensured. This demand for advanced laboratory equipment, especially those like carbon dioxide incubators, will increase significantly with continued investments in R&D and growing biotech companies that try to come up with new therapies.
A carbon dioxide incubator is a complex instrument that regulates temperature and gas environment. It has high upfront followed by maintenance and repair costs. The cost factor may be detrimental to the market growth mainly in developing countries where the laboratories and research institute have limited funds.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The table below offers a comparative analysis of the Compound Annual Growth Rate (CAGR) fluctuations for the global carbon dioxide incubators market between the base year (2023) and the current year (2024) over six months. This examination uncovers significant changes in market performance and highlights trends in revenue generation, giving stakeholders valuable insights into the market’s growth trajectory throughout the year. The first half (H1) encompasses January through June, while the second half (H2) covers July through December.
In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 5.9%, followed by a slightly lower growth rate of 5.6% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 5.9% (2023 to 2033) |
| H2 | 5.6% (2023 to 2033) |
| H1 | 5.1% (2024 to 2034) |
| H2 | 4.6% (2024 to 2034) |
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to decrease slightly to 5.1% in the first half and remain relatively moderate at 4.6% in the second half. In the first half (H1) the market witnessed a decrease of 80 BPS while in the second half (H2), the market witnessed a decrease of 100 BPS.
Rising Demand for Cell-Based Therapies drive Market
Cell-culture-based therapies such as stem cell treatments and regenerative medicine need very specific conditions to ensure the survival and functionality of the cells. CO2 incubators are necessary to provide a controlled atmosphere with precise regulation of temperature, humidity, and carbon dioxide levels. These exquisitely influence the cultivation of the cells and differentiation of several cell lineages. With increasing research in these fields, the need for CO2 incubators becomes essential.
Continuous development of novel therapy is essential to address the evolving resistant form of chronic disease. As such, the search by healthcare professionals and researchers for effective solutions to these requests makes the need for incubators with high operational reliability for therapeutic cell cultivation even more acute. This tendency is most evident in oncology, personalized medicine approaches through cell therapy is common
With the increase in laboratories and research institutes engaged in the development of newer therapies, good quality CO2 incubators also augment in order to assist the process. In a nutshell, the growing demand for advanced healthcare coupled with evolving cell-based therapies and significant on-going research efforts effectively raises demand for carbon dioxide incubators across the globe.
Expanding application of carbon dioxide incubators are Creating New Opportunities
As IVF techniques becomes more popular across worldwide, it is essential to meet the need for carbon dioxide incubators used in healthcare settings. Carbon dioxide incubators play a critical role in establishing the suitable conditions for a successful IVF act. With increased worldwide demand for assisted reproductive technologies, the dependence by IVF laboratories on CO2 incubators becomes even more imperative.
The best environment provided by these instruments in terms of temperature, humidity, and gas concentrations is found to be suitable for proper embryo growth that mimics the in vivo environment. Owing to their support for a stable temperature of around 37°C and 5% CO2 concentration, it enhances embryo development-the most significant factor that enables implantation and positive pregnancy results.
Also, due to the high incidence of infertility issues in developed countries the demand for IVF treatment have increased. As per the American Society of Reproductive Medicine, 89,208 baby were born through IVF in USA in the year of 2021. The number has raised to 91,771 in 2022, which is an increase of 2.5%. With growing demand IVF Procedure, the demand for efficient and reliable CO2 incubators to support the IVF has also grown.
Developing energy-efficient carbon dioxide incubators is a key trend in market
Since every laboratory is striving to reduce their carbon footprint, energy-efficient incubators naturally attract them. They are designed with advanced insulation materials, recovery systems, and low-power components that help hugely in reducing the amount of energy used. Lowering the use of energy can therefore help research facilities contribute toward the sustainable goals of reducing global greenhouse gases as envisioned by the world.
Furthermore, energy-efficient incubators reduce operation costs, which become vital in laboratories operated under tight budgets. Traditional incubators may be power-hungry and could result in very huge utility expenses for facilities that may be running incubators throughout. Significant savings can be realized by investing in energy-efficient models, and this would ensure that the said resources are channeled to other critical areas of research.
Manufacturers are focusing on increasing the efficiency of heating and cooling systems, Insulation, and Chamber Design. Focus has also been placed on complying with the regulatory norms such as DIN 12880:2007-05 for temperature control and safety.
Furthermore, increased regulatory pressure on sustainability performance in the life sciences sector forces manufacturers to develop and produce greener equipment. Energy-efficient CO2 incubators not only support this ever-growing demand for 'green' processes but also increase general efficiency and cost-effectiveness of laboratory operations, hence becoming very attractive to researchers all around the world.
High Upfront Cost Impede Carbon Dioxide Incubators Use Developing Economies
Carbon dioxide incubators are highly complex equipment, with complicated temperature and gas control systems so that the conditions for cell culture and other applications can be as close to ideal as possible. This equipment has considerable upfront investment required to buy and install them. Which can actually be repulsive to potential customers, particularly in regions where the budget is limited for laboratory equipment.
High costs can present a significant entry barrier, especially in developing economies, where resources to fund research and development might be constrained. Many research institutions or laboratories will hence have a very slow rate of diffusion as they would rather channel their limited funds into purchasing critical equipment than advanced incubators. More importantly, the high maintenance and operational costs associated with high-end incubators will further add to their cost, so investment will be further discouraged.
Furthermore, this could be made even more complicated due to the lack of infrastructure and supporting services in such areas. If it is not possible to secure access to maintenance and technical support for operation, buyers will be less interested in purchasing very expensive equipment. Hence, the expensive upfront costs of carbon dioxide incubators will go a long way in preventing them from diffusing in developing regions, consequently making them unavailable and inaccessible to researchers and health professionals that could have otherwise benefited from a myriad of their improved features.
Principal Consultant
The carbon dioxide incubators industry recorded a CAGR of 5.1% between 2019 and 2023. According to the industry, carbon dioxide incubators generated USD 716.4 million in 2023, up from USD 575.0 million in 2019.
There have been rise in the prevalence of infertility and surge in acceptance of assisted reproductive technologies, particularly in vitro fertilization (IVF). According to the data provided by WHO, about 17.5% of adults (1 in 6) are affected with infertility. As more and more couples seek fertility treatment, demand for CO2 incubators that provide optimal conditions for embryo development has surged. If successful IVF is to be achieved, incubators would then play a very critical role in simulating the physiological uterus environment.
One major driving force for the biotechnology and life sciences market is just that-advancements in biotechnology. An increased number of research studies and development activities in areas such as personalized medicine, regenerative treatments, and drug discovery have been underway, all requiring a controlled cell culture environment. The CO2 incubator is used in the cultivation of cell lines and primary cells associated with a disease process under study and in the development of novel therapies.
Apart from that, the development in CO2 incubators, such as reduction in contamination, automation of operations, and user-friendliness, enhances their appeal to researchers and clinicians. Each of these improvements in operational efficiency and reliability in results output fuels further growth in demand. Thus, over the next few years, the market for carbon dioxide incubators is likely to make huge growth in view of the continuous rise in infertility rates, improvements in biotechnology, and technological advancements.
Companies in the Tier 1 sector account for 60.9% of the global market, ranking them as the dominant players in the industry. Tier 1 player’s offer a wide range of products related to research laboratories, have an established industry presence, offer continuous innovation, and have a significant influence in the field.
The companies in the tier 1 category have sufficient financial resource at their disposal to increase their research and development efforts. Owing to the strong brand recognition and loyal customer base provide them with a competitive edge. Prominent companies within Tier 1 include Thermo Fisher Scientific Inc., Eppendorf, and BINDER GmbH.
Tier 2 players dominate the industry with a 28.9% market share. Tier 2 firms have a strong focus on a specific technology and a substantial presence on the industry, but they have less influence than Tier 1 firms. The players are more competitive when it comes to pricing and target niche markets. New products and services will also be introduced into the industry by Tier 2 companies. Tier 2 companies include Cardinal Health, Bellco Glass, Sheldon Manufacturing Inc., and Sartorius AG among others.
Compared to Tiers 1 and 2, Tier 3 companies have smaller revenue spouts and less influence. Those in Tier 3 has smaller work force and limited presence across the globe. Prominent players in the tier 3 category are Shanghai Boxun Medical Biological Instrument Corp., LEEC Ltd., and NuAire Inc.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section below covers the industry analysis for the carbon dioxide incubators market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Latin America, East Asia, South Asia, Western Europe, Eastern Europe, and Middle East and Africa (MEA), is provided. The United States is anticipated to remain at the forefront in North America, with a value share of 78.6% through 2034. In Asia Pacific, India is projected to witness a CAGR of 5.8% by 2034.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| Canada | 2.8% |
| Germany | 1.6% |
| France | 2.6% |
| Italy | 2.3% |
| China | 5.1% |
| India | 5.8% |
| Japan | 2.1% |
The USA carbon dioxide incubators industry is expected to grow at 1.6% CAGR from 2024 to 2034. The USA comprises of a few reputed universities, research laboratories, and pharmaceutical manufacturers that engage on a large scale usage of laboratory instruments, including CO2 incubators, for a number of applications such as cell culture, drug testing, and tissue engineering. Besides, the rising incidence of infertility have seen a gradual shifted toward IVF treatment which also accelerates the demand for CO2 incubators in IVF clinics.
Reports indicate that of the patients being treated for fertility disorders, a good percentage are undergoing IVF, thereby creating demand for incubators that can provide ideal conditions for incubation and subsequent development of embryos.
Apart from that, improving design and functionality of CO2 incubators, higher temperature stability, user-friendly interfaces, and advanced contamination control are raising their potential for application in research and clinical settings. The strong presence of key players such as Thermo Fisher Scientific and Eppendorf also underpins the competitive landscape of the market in terms of innovation and product development.
Substantial investments are being made by the Chinese government toward building healthcare infrastructure which have resulted in increased research and development activity in the areas of biotechnology sector. The research and development investment of The Ministry of Science and Technology of China rose 8.1% in 2023 to over USD 458 billion.
This thus becomes a very important investment, as advanced medical technologies and therapies in the process of development demand complex laboratory equipment, including CO2 incubators. On the other hand, infertility and cases of chronic diseases among the Chinese population are on the rise, and therefore surging demands for assisted reproductive technologies, especially in vitro fertilization.
With more and more couples seeking fertility treatments, the requirement of reliable CO2 incubators to help in optimal conditions for embryo development increases. The combination of the government investment in healthcare and the increasing infertility rate places China as the key player in propelling the carbon dioxide incubators market.
In Japan, the growth of carbon dioxide incubators has been highly affected by the demographic challenges and the latest developments in reproductive technologies. Moreover, the country has a low birth rate with an aging population, which has been continuously exerting potential social and economic pressure on it. The government is, therefore, encouraging assisted reproductive technologies, such as in vitro fertilization, to help grow families.
The Japanese Prime Minister declared his intention to push for the inclusion of IVF and fertility treatment into the national health insurance by 2022 so that more couples can get assistance in infertility problems. This declaration will reduce the financial burden associated with fertility treatment, hence increasing the uptake of the same.
Japan is a leader in stem cell engineering and regenerative medicine making it reliant on CO2 incubators for establishing optimal cell culture conditions. Increased investment in the development of state-of-the-art medical solutions has been noted in the country. The aforementioned factors makes Japan an important market for carbon dioxide incubators. The Japanese market is likely to grow at a CAGR of 2.1% during the period 2024 to 2034.
A description of the leading segments in the industry is provided in this section. The in vitro fertilization segment held 46.2% of the value share in 2024. Based on the capacity, 100-200 Liter held 46.5% of the market in 2024.
| Application | In Vitro Fertilization |
|---|---|
| Value Share (2024) | 46.2% |
In Vitro Fertilization is expected to contribute around 46.2% of market size in 2024. Infertility in couples has increased significantly owing to changes in lifestyles, environmental factors, and late marriages. According to the National Institute of Child Health and Human Development, about 9% of men and about 11% of women of childbearing age in the United States have used fertility services. Besides, the acceptance for assisted reproduction techniques like IVF is gradually increasing.
This stigma associated with these treatments reduces as more and more couples are now willing to discuss infertility openly, sticking to changing social customs and seeking medical help.
CO2 incubators find their application in IVF since they are of great importance in maintaining the correct conditions for the development of an embryo. They provide a constant temperature of approximately 37°C, which is essential for the viability of the embryo. They regulate CO2, normally around 5-6%, necessary for establishing a correctly balanced pH in the culture medium required for the healthiness of the embryo. However, low oxygen tension, always maintained in the incubators, promotes the development of the embryo and raises the chances of successful implantation.
| Capacity | 100-200 Liter |
|---|---|
| Value Share (2024) | 46.5% |
100-200 Liter capacity segment is expected to contribute around 46.5 % of market size in 2024. The 100-200 liter capacity incubator is ideal for medium scale laboratories and research facilities. It provides a balance between the scalability and space efficiency. They have sufficient volume suitable for accommodating numerous applications. This application includes cell culture, microbiology, and tissue engineering. Also there have been rise in the demand for cell based therapies and in vitro fertilization which in turn have amplified the demand for CO2 incubator.
Various factor influences consumer spending and the uncertain event such as pandemic together results in the fluctuating market demand. To address these variation in the market demand 100-200 liter incubator is ideal for medium scale laboratories.
Since the number of medium scale laboratory establishment is higher than small and large scale one the market share for the same is largest. While the labs are expanding in their capabilities, the focus is more on maximizing research capabilities with optimum conditions for cell growth and experimentation. This increased investments in health care and research infrastructures, further fuels the demand for 100-200 liter incubators.
Industry players manufacturing carbon dioxide incubators sector are prioritizing on developing user friendly product, which improved features and functionality. Focus is being placed on developing products that can offer better control over environmental parameter, reduce temperature fluctuations, reduce contamination etc. These incubators can be integrated into automated and modular laboratories.
This feature increased the operational efficiency of the laboratories. Attention have also been given to the scalability of the product. This product development are in response to market demand for scalable, efficient incubator. This growing demand have resulted in launch of many innovative CO2 by market players to gain a competitive edge over their rivals and increase revenue.
Recent Industry Developments in the Carbon Dioxide Incubators Market
In terms of product type, the industry is segregated into water jacketed CO2 incubators, air jacketed CO2 incubators, and direct heat CO2 incubators.
In terms of capacity, the industry is segmented into below 100 liter, 100-200 liter, and above 200 liter.
In terms of application, the industry is bifurcated into laboratory research and clinical applications, in vitro fertilization, and others.
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia, East Asia, Middle East, and Africa have been covered in the report.
Carbon Dioxide Incubators industry is expected to increase at a CAGR of 5.1% between 2024 and 2034.
The 100-200 Liter segment is expected to occupy a 46.5% market share in 2024.
The market for carbon dioxide incubators is expected to reach USD 1,238.1 million by 2034.
The United States is forecast to see a CAGR of 1.6% during the assessment period.
The key players in the carbon dioxide incubators industry include Eppendorf, Thermo Fisher Scientific Inc., BINDER GmbH, Cardinal Health, Bellco Glass, Sheldon Manufacturing Inc., Shanghai Boxun Medical Biological Instrument Corp., Sartorius AG, LEEC Ltd., and NuAire Inc.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Pricing Analysis 5. Global Market Size Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 6.1. By Product 6.2. By Capacity 6.3. By Application 6.4. By Region 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 7.1. Water Jacketed CO2 Incubators 7.2. Air Jacketed CO2 Incubators 7.3. Direct Heat CO2 Incubators 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Capacity 8.1. Below 100 Litre 8.2. 100-200 Litre 8.3. Above 200 Litre 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Application 9.1. Laboratory Research and Clinical Applications 9.2. In Vitro Fertilization 9.3. Others 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 10.1. North America 10.2. Latin America 10.3. East Asia 10.4. South Asia and Pacific 10.5. Western Europe 10.6. Eastern Europe 10.7. Middle East and Africa 11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Middle East and Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 18. Sales Forecast 2024 to 2034 By Product, Capacity, and Application for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. Eppendorf 20.2. Thermo Fisher Scientific Inc. 20.3. BINDER GmbH 20.4. Cardinal Health 20.5. Bellco Glass 20.6. Sheldon Manufacturing Inc. 20.7. Shanghai Boxun Medical Biological Instrument Corp. 20.8. Sartorius AG 20.9. LEEC Ltd. 20.10. NuAire Inc.
Explore Healthcare Insights
View Reports
Carbon Dioxide Incubators Market
